Post-translational modifications of Kaposi's sarcoma-associated herpesvirus regulatory proteins - SUMO and KSHV

被引:32
|
作者
Campbell, Mel [1 ]
Izumiya, Yoshihiro [1 ]
机构
[1] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
KSHV; LANA; K-bZIP; K-Rta; SUMO; post-translational modification; transcription; LATENT NUCLEAR ANTIGEN; SIMPLEX-VIRUS TYPE-1; READING FRAME 50; HUMAN CYTOMEGALOVIRUS; UBIQUITIN LIGASE; BINDING PROTEIN; POLY(ADP-RIBOSE) POLYMERASE-1; TRANSCRIPTIONAL REPRESSION; STE20-LIKE KINASE; HISTONE CHAPERONE;
D O I
10.3389/fmicb.2012.00031
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
KSHV latency can be envisioned as an outcome that is balanced between factors that promote viral gene expression and lytic replication against those that facilitate gene silencing and establish or maintain latency. A large body of work has focused on the activities of the key viral regulatory proteins involved in KSHV latent or lytic states. Moreover, recent studies have also begun to document the importance of epigenetic landscape evolution of the KSHV viral genome during latency and reactivation. However, one area of KSHV molecular virology that remains largely unanswered is the precise role of post-translational modifications on the activities of viral factors that function during latency and reactivation. In this review, we will summarize the post-translational modifications associated with three viral factors whose activities contribute to the viral state. The viral proteins discussed are the two major KSHV encoded transcription factors, K-Rta (KSHV replication and transcriptional activator) and K-bZIP (KSHV basic leucine zipper) and the viral latency-associated nuclear antigen (LANA). A special emphasis will be placed on the role of the sumoylation pathway in the modulation of the KSHV lifecycle. Newly uncovered small ubiquitin-like modifier (SUMO)-associated properties of LANA and K-Rta will also be presented, namely LANA histone targeting SUMO E3 ligase activity and K-Rta SUMO-targeted ubiquitin ligase function.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Kaposi Sarcoma-Associated Herpesvirus (KSHV)
    Lange, Philip
    Damania, Blossom
    TRENDS IN MICROBIOLOGY, 2020, 28 (03) : 236 - 237
  • [2] Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)
    Chatlynne, LG
    Ablashi, DV
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 175 - 185
  • [3] Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV)
    Shifflett, Kyle W.
    Dittmer, Dirk P.
    VIROLOGY, 2025, 603
  • [4] Virion proteins of Kaposi's sarcoma-associated herpesvirus
    Zhu, FX
    Chong, JM
    Wu, LJ
    Yuan, Y
    JOURNAL OF VIROLOGY, 2005, 79 (02) : 800 - 811
  • [5] Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases
    Asahi-Ozaki, Y
    Sato, Y
    Kanno, T
    Sata, T
    Katano, H
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (06): : 773 - 782
  • [6] Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
    M Dedicoat
    R Newton
    British Journal of Cancer, 2003, 88 : 1 - 3
  • [7] Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
    Dedicoat, M
    Newton, R
    BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 1 - 3
  • [8] Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation
    Nakajima, Ken-ichi
    Inagaki, Tomoki
    Espera, Jonna Magdallene
    Izumiya, Yoshihiro
    JOURNAL OF VIROLOGY, 2024, 98 (02)
  • [9] Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis
    Wen, Kwun Wah
    Damania, Blossom
    CANCER LETTERS, 2010, 289 (02) : 140 - 150
  • [10] Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma
    Gruffat, H
    Sergeant, A
    Manet, E
    MICROBES AND INFECTION, 2000, 2 (06) : 671 - 680